Mode
Text Size
Log in / Sign up
N/A Completed N=50 Randomized Triple-blind Treatment

Vistakon Investigational Lens Worn as a Single Use Daily Wear

Source: ClinicalTrials.gov NCT01031004 ↗
Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Mar 2011
Primary outcomePrimary: Slit Lamp Findings - Corneal Edema — 0; 0 eyes

Summary

This study is intended to show that the investigational contact lens is clinically equivalent to a currently approved contact lens, when worn as single-use on a daily basis.

Outcome Measures

OutcomeResultp-value
PRIMARY
Slit Lamp Findings - Corneal Edema
0; 0 —
PRIMARY
Corneal Edema at Month 1
0; 0 —
PRIMARY
Slit Lamp Findings - Corneal Neovascularization
0; 0 —
PRIMARY
Slit Lamp Findings - Corneal Staining
1; 0 —
PRIMARY
Slit Lamp Findings - Injection
0; 0 —
PRIMARY
Slit Lamp Findings - Tarsal Abnormalities
0; 0 —
PRIMARY
Slit Lamp Findings - Infiltrates
0; 0 —
PRIMARY
Subject Reported Symptoms
14; 5 0.1069
PRIMARY
Visual Acuity (VA)
0; 0 0.5774
PRIMARY
Average Wear Time
13.6; 13.8 0.7217

Eligibility Criteria

Inclusion Criteria

  • eyes must be best-corrected to a visual acuity of 20/30 or better in each eye
  • must be able and willing to wear soft contact lenses on a single use, daily wear basis for the duration of the study
  • distance spherical contact lens prescription must be within the range available for the study

Exclusion Criteria

  • systemic diseases which may interfere with contact lens wear
  • ocular infection or clinically significant ocular disease
  • any previous intraocular surgery
  • grade 2 or greater slit lamp findings
  • currently pregnant or lactating
  • more than 1.00D of refractive astigmatism in either eye
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01031004). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search